California State Teachers Retirement System Trims Stake in Halyard Health Inc (NYSE:HYH)

California State Teachers Retirement System trimmed its holdings in shares of Halyard Health Inc (NYSE:HYH) by 9.6% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 74,862 shares of the medical instruments supplier’s stock after selling 7,979 shares during the period. California State Teachers Retirement System owned 0.16% of Halyard Health worth $3,371,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of the business. OxFORD Asset Management LLP grew its position in shares of Halyard Health by 24.8% during the third quarter. OxFORD Asset Management LLP now owns 69,175 shares of the medical instruments supplier’s stock worth $3,155,000 after acquiring an additional 13,761 shares during the last quarter. Dimensional Fund Advisors LP grew its position in shares of Halyard Health by 5.1% during the third quarter. Dimensional Fund Advisors LP now owns 3,292,483 shares of the medical instruments supplier’s stock worth $148,262,000 after acquiring an additional 159,434 shares during the last quarter. Wells Fargo & Company MN grew its position in shares of Halyard Health by 5.8% during the third quarter. Wells Fargo & Company MN now owns 514,776 shares of the medical instruments supplier’s stock worth $23,180,000 after acquiring an additional 28,265 shares during the last quarter. Paradice Investment Management LLC grew its position in shares of Halyard Health by 2.1% during the third quarter. Paradice Investment Management LLC now owns 1,564,813 shares of the medical instruments supplier’s stock worth $70,464,000 after acquiring an additional 31,832 shares during the last quarter. Finally, Legal & General Group Plc grew its position in shares of Halyard Health by 7.1% during the third quarter. Legal & General Group Plc now owns 76,356 shares of the medical instruments supplier’s stock worth $3,442,000 after acquiring an additional 5,043 shares during the last quarter. 89.32% of the stock is currently owned by institutional investors.

Several equities analysts have recently commented on HYH shares. TheStreet lowered shares of Halyard Health from a “b-” rating to a “c+” rating in a research report on Monday, October 30th. Zacks Investment Research upgraded shares of Halyard Health from a “hold” rating to a “buy” rating and set a $53.00 price target for the company in a research report on Thursday, January 4th. ValuEngine upgraded shares of Halyard Health from a “hold” rating to a “buy” rating in a research report on Saturday, November 4th. KeyCorp reiterated a “hold” rating on shares of Halyard Health in a research report on Tuesday, October 17th. Finally, Stifel Nicolaus reiterated a “buy” rating and issued a $52.00 target price on shares of Halyard Health in a research report on Friday, November 3rd. One equities research analyst has rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average price target of $49.00.

Shares of Halyard Health Inc (HYH) traded up $0.11 on Thursday, reaching $48.92. 340,616 shares of the company were exchanged, compared to its average volume of 295,751. The company has a market cap of $2,290.00, a price-to-earnings ratio of 41.11, a PEG ratio of 2.58 and a beta of 1.76. The company has a quick ratio of 1.19, a current ratio of 2.13 and a debt-to-equity ratio of 0.49. Halyard Health Inc has a 12-month low of $35.24 and a 12-month high of $50.99.

Halyard Health (NYSE:HYH) last announced its earnings results on Wednesday, November 1st. The medical instruments supplier reported $0.60 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.47 by $0.13. The firm had revenue of $401.40 million during the quarter, compared to analyst estimates of $394.54 million. Halyard Health had a net margin of 3.52% and a return on equity of 8.65%. Halyard Health’s revenue was up 1.0% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.48 EPS. research analysts anticipate that Halyard Health Inc will post 2.08 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: This news story was first published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this news story on another website, it was illegally stolen and reposted in violation of United States & international trademark and copyright law. The legal version of this news story can be viewed at https://www.dispatchtribunal.com/2018/02/01/halyard-health-inc-hyh-holdings-trimmed-by-california-state-teachers-retirement-system.html.

Halyard Health Profile

Halyard Health, Inc is a medical technology company. The Company operates through two segments: Medical Devices and Surgical and Infection Prevention (S&IP). The Medical Devices segment provides a portfolio of product offerings focused on pain management, respiratory and digestive health. The S&IP segment provides healthcare supplies and solutions that target the prevention of healthcare-associated infections.

Institutional Ownership by Quarter for Halyard Health (NYSE:HYH)

Receive News & Ratings for Halyard Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Halyard Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply